Hepatocyte-specific perturbation of NAD(+) biosynthetic pathways in mice induces reversible nonalcoholic steatohepatitis–like phenotypes

por Dall, Morten, Hassing, Anna S., Niu, Lili, Nielsen, Thomas S., Ingerslev, Lars R., Sulek, Karolina, Trammell, Samuel A.J., Gillum, Matthew P., Barrès, Romain, Larsen, Steen, Poulsen, Steen S., Mann, Matthias, Ørskov, Cathrine, Treebak, Jonas T.
Publicado 2021

Investigation of the specificity and mechanism of action of the ULK1/AMPK inhibitor SBI-0206965

por Ahwazi, Danial, Neopane, Katyayanee, Markby, Greg R., Kopietz, Franziska, Ovens, Ashley J., Dall, Morten, Hassing, Anna S., Gräsle, Pamina, Alshuweishi, Yazeed, Treebak, Jonas T., Salt, Ian P., Göransson, Olga, Zeqiraj, Elton, Scott, John W., Sakamoto, Kei
Publicado 2021

Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis

por Winther-Sørensen, Marie, Galsgaard, Katrine D., Santos, Alberto, Trammell, Samuel A.J., Sulek, Karolina, Kuhre, Rune E., Pedersen, Jens, Andersen, Daniel B., Hassing, Anna S., Dall, Morten, Treebak, Jonas T., Gillum, Matthew P., Torekov, Signe S., Windeløv, Johanne A., Hunt, Jenna E., Kjeldsen, Sasha A.S., Jepsen, Sara L., Vasilopoulou, Catherine G., Knop, Filip K., Ørskov, Cathrine, Werge, Mikkel P., Bisgaard, Hanne Cathrine, Eriksen, Peter Lykke, Vilstrup, Hendrik, Gluud, Lise Lotte, Holst, Jens J., Wewer Albrechtsen, Nicolai J.
Publicado 2020